Corgenix Medical Corp. (fka CONX)

[levelnever]

This fact, and this fact alone, should be something that makes people wonder, not to mention should absolutely have been in the filings.

Not just being paid $100,000 by largest shareholder Wescor for closing merger, the person in charge of merger deal from company side, David Ludvigson, was also CEO of this competitor/partner company, Nanomix. This was not revealed in any of the merger filings. Seems relevant to me and a significant oversight.

Read this and tell me there is no conflict of interest:

http://www.newrepublic.com/article/119711/nanomix-produces-diagnostic-device-test-ebola-just-minutes

the solution for rapid, in-the-field testing likely won’t be Corgenix’s device. It will be a different diagnostic test developed by a California company called Nanomix, which has partnered with Corgenix and Tulane researchers. The Nanomix test is a multiplex device: It can detect multiple diseases at once. This is particularly important in West Africa, where Lassa fever, malaria, and now Ebola are all prevalent. All three of those diseases have similar symptoms—fever, vomiting, diarrhea—but require different treatments. It’s vital for doctors to have a correct diagnosis as early as possible. Nanomix’s device would do just that in minutes.

The Nanomix system is simple and safe. The tested blood is self-contained and easy to dispose. “You take whole blood from a patient and you put the whole blood into an inlet port on the cartridge and then you put that cartridge [and] slide it into the reader,” said David Ludvigson, the CEO of Nanomix. “And then the operator presses the start button. … The cartridge itself contains all of the biology and all of the patient’s sample and the instrument never sees that. It becomes bio disposable.”

Nanomix was focused on cardivascular health testing and suddenly came into the Ebola play only middle of last year.